Home/Filings/4/0001209191-21-023006
4//SEC Filing

Crouch Bronson 4

Accession 0001209191-21-023006

CIK 0001789769other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:27 PM ET

Size

19.0 KB

Accession

0001209191-21-023006

Insider Transaction Report

Form 4
Period: 2021-03-23
Crouch Bronson
DirectorCEO and Chairman10% Owner
Transactions
  • Conversion

    Common Stock

    2021-03-23+6,098,79936,098,799 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-03-23+1,431,27437,530,073 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock

    2021-03-2325,000,0000 total(indirect: See footnote)
    Common Stock (30,000,000 underlying)
  • Conversion

    Series B Preferred Stock

    2021-03-235,082,3330 total(indirect: See footnote)
    Common Stock (6,098,799 underlying)
  • Purchase

    Common Stock

    2021-03-23$20.00/sh+450,000$9,000,00037,980,073 total(indirect: See footnote)
  • Conversion

    Series C Preferred Stock

    2021-03-231,192,7290 total(indirect: See footnote)
    Common Stock (1,431,274 underlying)
  • Conversion

    Common Stock

    2021-03-23+30,000,00030,000,000 total(indirect: See footnote)
Holdings
  • Common Stock

    2,537,873
  • Common Stock

    (indirect: See footnote)
    2,399,999
Footnotes (3)
  • [F1]Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.
  • [F2]The securities are held by Curative Ventures V LLC (the "LLC"). CV-Immetacyte Ultimate Manager LLC ("Ultimate Manager") is the general partner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims Section 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F3]The securities are held by SB2A LP. The Reporting Person is the manager of SB2A Management LLC, the general partner and manager of SB2A LP.

Issuer

Instil Bio, Inc.

CIK 0001789769

Entity typeother

Related Parties

1
  • filerCIK 0001851041

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:27 PM ET
Size
19.0 KB